JP2020527607A - 非炎症性病変の処置 - Google Patents

非炎症性病変の処置 Download PDF

Info

Publication number
JP2020527607A
JP2020527607A JP2020524697A JP2020524697A JP2020527607A JP 2020527607 A JP2020527607 A JP 2020527607A JP 2020524697 A JP2020524697 A JP 2020524697A JP 2020524697 A JP2020524697 A JP 2020524697A JP 2020527607 A JP2020527607 A JP 2020527607A
Authority
JP
Japan
Prior art keywords
methyl
lesions
therapeutically effective
weeks
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020524697A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020527607A5 (enExample
Inventor
デイビッド・バーク
アレクサンドル・カオウホフ
ビルマ・スニウキーン
カーステン・シュミッツ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall LLC
Original Assignee
Almirall LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall LLC filed Critical Almirall LLC
Publication of JP2020527607A publication Critical patent/JP2020527607A/ja
Publication of JP2020527607A5 publication Critical patent/JP2020527607A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020524697A 2017-07-21 2018-07-20 非炎症性病変の処置 Pending JP2020527607A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762535572P 2017-07-21 2017-07-21
US62/535,572 2017-07-21
PCT/IB2018/000938 WO2019016609A1 (en) 2017-07-21 2018-07-20 TREATMENT OF NON-INFLAMMATORY LESIONS

Publications (2)

Publication Number Publication Date
JP2020527607A true JP2020527607A (ja) 2020-09-10
JP2020527607A5 JP2020527607A5 (enExample) 2021-02-25

Family

ID=63713912

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020524697A Pending JP2020527607A (ja) 2017-07-21 2018-07-20 非炎症性病変の処置

Country Status (13)

Country Link
US (1) US20200222432A1 (enExample)
EP (1) EP3654988B1 (enExample)
JP (1) JP2020527607A (enExample)
KR (1) KR102662461B1 (enExample)
CN (1) CN111343991A (enExample)
AU (1) AU2018303807B2 (enExample)
BR (1) BR112020000968A2 (enExample)
CA (1) CA3070663A1 (enExample)
ES (1) ES2962380T3 (enExample)
IL (1) IL272124A (enExample)
MA (1) MA49641A (enExample)
MX (1) MX2020000816A (enExample)
WO (1) WO2019016609A1 (enExample)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079363A2 (en) * 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
JP2010505827A (ja) * 2006-10-03 2010-02-25 ドウ ファーマシューティカル サイエンシーズ 結節性座瘡治療用アジスロマイシン
JP2013500984A (ja) * 2009-07-30 2013-01-10 アラーガン、インコーポレイテッド ダプソンとアダパレンの組み合わせ
JP2014520077A (ja) * 2011-05-12 2014-08-21 パラテック ファーマシューティカルズ インコーポレイテッド （４ｓ，４ａｓ，５ａｒ，１２ａｓ）−４−ジメチルアミノ−３，１０，１２，１２ａ−テトラヒドロキシ−７−［（メトキシ（メチル）アミノ）−メチル］−１，１１−ジオキソ−１，４，４ａ，５，５ａ，６，１１，１２ａ−オクタヒドロ−ナフタセン−２−カルボン酸アミドの結晶塩及びそれを使用する方法
JP2015038093A (ja) * 2008-06-05 2015-02-26 ドウ ファーマシューティカル サイエンシーズ、インク． 水及び水混和性有機溶媒中に懸濁する低濃度過酸化ベンゾイルを含む局所用医薬品製剤
WO2018051102A1 (en) * 2016-09-15 2018-03-22 Antibiotx A/S Combinations comprising dibromopropamidine or diminazene and a tetracycline anti-bacterial agent

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990331A (en) 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
US2980584A (en) 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US3062717A (en) 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3165531A (en) 1962-03-08 1965-01-12 Pfizer & Co C 13-substituted-6-deoxytetracyclines and process utilizing the same
US3454697A (en) 1965-06-08 1969-07-08 American Cyanamid Co Tetracycline antibiotic compositions for oral use
NL6607516A (enExample) 1966-05-31 1967-12-01
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
DE2442829A1 (de) 1974-09-06 1976-03-18 Merck Patent Gmbh Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en) 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4126680A (en) 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
DE60212613T2 (de) * 2001-04-05 2007-05-24 Collagenex Pharmaceuticals, Inc. Doxycyclin zur behandlung von akne
ES2548261T3 (es) 2006-12-21 2015-10-15 Paratek Pharmaceuticals, Inc. Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias
WO2009141406A1 (en) * 2008-05-21 2009-11-26 Galderma Research & Development Maintenance therapy regimen for treating acne
US20140121188A1 (en) * 2009-10-02 2014-05-01 Foamix Ltd. Compositions for the improved treatment of acne and related disorders
US20150164922A1 (en) * 2012-03-15 2015-06-18 Foamix Pharmaceuticals Ltd. Use of tetracycline compositions for wound treatment and skin restoration

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010505827A (ja) * 2006-10-03 2010-02-25 ドウ ファーマシューティカル サイエンシーズ 結節性座瘡治療用アジスロマイシン
WO2008079363A2 (en) * 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
JP2015038093A (ja) * 2008-06-05 2015-02-26 ドウ ファーマシューティカル サイエンシーズ、インク． 水及び水混和性有機溶媒中に懸濁する低濃度過酸化ベンゾイルを含む局所用医薬品製剤
JP2013500984A (ja) * 2009-07-30 2013-01-10 アラーガン、インコーポレイテッド ダプソンとアダパレンの組み合わせ
JP2014520077A (ja) * 2011-05-12 2014-08-21 パラテック ファーマシューティカルズ インコーポレイテッド （４ｓ，４ａｓ，５ａｒ，１２ａｓ）−４−ジメチルアミノ−３，１０，１２，１２ａ−テトラヒドロキシ−７−［（メトキシ（メチル）アミノ）−メチル］−１，１１−ジオキソ−１，４，４ａ，５，５ａ，６，１１，１２ａ−オクタヒドロ−ナフタセン−２−カルボン酸アミドの結晶塩及びそれを使用する方法
WO2018051102A1 (en) * 2016-09-15 2018-03-22 Antibiotx A/S Combinations comprising dibromopropamidine or diminazene and a tetracycline anti-bacterial agent

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CLINICAL TRAIALS.GOV NCT01628549, [ONLINE], JPN6021043796, 26 June 2012 (2012-06-26), ISSN: 0004854449 *
J AM ACAD DERMATOL, JPN6021043795, June 2017 (2017-06-01), pages 1113 - 5341, ISSN: 0004854448 *
JOURNAL OF DRUGS IN DERMATOLOGY, vol. Vol.7, ISSUE3, JPN6021043797, March 2018 (2018-03-01), pages 333 - 338, ISSN: 0004636326 *

Also Published As

Publication number Publication date
EP3654988B1 (en) 2023-09-06
AU2018303807B2 (en) 2023-08-24
MA49641A (fr) 2021-06-02
CN111343991A (zh) 2020-06-26
ES2962380T3 (es) 2024-03-18
BR112020000968A2 (pt) 2020-07-14
MX2020000816A (es) 2020-08-17
WO2019016609A1 (en) 2019-01-24
IL272124A (en) 2020-03-31
EP3654988A1 (en) 2020-05-27
CA3070663A1 (en) 2019-01-24
KR20200031126A (ko) 2020-03-23
US20200222432A1 (en) 2020-07-16
AU2018303807A1 (en) 2020-02-13
KR102662461B1 (ko) 2024-04-30

Similar Documents

Publication Publication Date Title
JP5744976B2 (ja) にきびの治療方法発明の分野
US20030082120A1 (en) Method for reducing systemic effects of aging, effects of aging on the skin, and incidence of skin damage from sun exposure using antibiotics of the tetracycline family
US20070161566A1 (en) Method of treating multiple sclerosis
BRPI0614091A2 (pt) composição farmacêutica sólida de liberação extendida contendo carbidopa e levodopa
KR20100052556A (ko) 난청 치료 및 예방을 위한 1-아미노-알킬시클로헥산 유도체
JP2007302657A (ja) 痙症の兆候および症候の緩和方法
CN119486713A (zh) 尼罗加司他治疗
JP2021502392A5 (enExample)
RU2762754C2 (ru) Композиция для применения в предупреждении и/или лечении индуцированного онкологическим лечением мукозита полости рта и желудочно-кишечного тракта
CN109069450A (zh) 神经障碍的新的组合疗法
RU2751504C2 (ru) Применение карбамата для предупреждения или лечения невралгии тройничного нерва
CN112770765B (zh) 用于预防和/或治疗泌尿生殖器粘膜的组合物
JP2020527607A (ja) 非炎症性病変の処置
HK40019815B (en) Sarecycline for the treatment of non-inflammatory acne lesions
HK40019815A (en) Sarecycline for the treatment of non-inflammatory acne lesions
CN103635194B (zh) 用于治疗早泄的药物组合物以及用于治疗早泄的方法
JPWO2006043336A1 (ja) 胃粘膜疾患の治療又は予防のための組成物
US12036230B2 (en) PTEN inhibitors for treatment and prevention of bone marrow loss
Savosina et al. Modern therapeutic approaches to the treatment of anal fissure
JP2018536690A (ja) 皮膚障害の治療用医薬製剤、ならびにその製造方法および用法
CN112137992A (zh) 一种用于治疗牙周炎的组合物及其用途
JP2020527607A5 (enExample)
CN114984034A (zh) 一种寡糖类化合物的应用
WO2011058982A1 (ja) 消化器疾患治療剤
HK40003859B (en) Use of carbamate compound for preventing or treating trigeminal neuralgia

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210112

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210112

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20211027

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211109

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220208

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220823